Discordance of c-MYC mRNA overexpression between the primary and distant metastatic cancer was detected in 25.6 % (45 out of 176) of cases, and discordance between the primary and lymph node metastatic cancer was observed in 30.6 % (34 out of 111) of cases. This evidence concerns the gene MYC and metastatic malignant neoplasm.